4
1
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
TP2245 |
Endostatin (84-114)-NH2 (JKC367)
|
Others | Others |
Endostatin is a potent inhibitor of primary tumor growth and endothelial cell proliferation and migration. Recombinant endostatin potently inhibited angiogenesis, maintains metastases at a low level, and suppressed tumors, a reduction of over 150-fold. En | |||
TP1925L |
tcY-NH2 TFA(327177-34-4 free base)
|
Protease-activated Receptor | GPCR/G Protein |
tcY-NH2 TFA(327177-34-4 free base) 是一种选择性 PAR4 拮抗肽。抑制凝血酶诱导的内皮抑素释放和血小板聚集。 | |||
TP1925 |
tcY-NH2
|
||
Selective PAR4 antagonist peptide. Inhibits endostatin release and platelet aggregation induced by thrombin. | |||
T75874 |
tcY-NH2 TFA
|
||
tcY-NH2 ((trans-Cinnamoyl)-YPGKF-NH2) TFA 是一种有效的 PAR4选择性肽类拮抗剂。tcY-NH2 TFA 抑制凝血酶和 AY-NH2诱导的血小板聚集和内皮抑素释放,可用于炎症、免疫学的研究。 |
Cat. No. | Product Name | Species | Expression System |
---|---|---|---|
TMPJ-00948 |
Endostatin Protein, Mouse, Recombinant (His)
antiangiogenic agent,type XVIII,collagen α-1(XVIII)chain,col... |
Mouse | HEK293 Cells |
Endostatin, an endogenous non‑glycosylated inhibitor of endothelial cell proliferation and angiogenesis. It is produced and/or trimmed by metalloproteinases such as MMP‑2 and MMP‑9, and cathepsins S, B and L. The N‑terminal ~27 aa of Endostatin appear to contain the majority of its activity. This region contains zinc binding sites that are thought to be critical for its anti‑endothelial and anti‑tumor effects, as well as multiple cleavage sites that, when used, can modify its activity. Mouse End... |